This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Rite Aid (RAD) to Report Q2 Earnings: What Should You Know?
by Zacks Equity Research
Rite Aid (RAD) is likely to have gained from PBM, RxEvolution strategy and expanded omnichannel services in Q2. Rising wage costs and drab front-end same-store sales are likely to have been concerns.
Earnings Preview: Rite Aid (RAD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 8th
by Zacks Equity Research
CLPR, IONS, RAD, TFFP, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on July 8, 2021
Alpha & Omega Semiconductor, Rite Aid, PayPal, Discover Financial and American Express highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Alpha & Omega Semiconductor, Rite Aid, PayPal, Discover Financial and American Express highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Rite Aid (RAD)
by David Bartosiak
The competition is fierce and earnings are moving in the wrong direction
New Strong Sell Stocks for July 6th
by Zacks Equity Research
DXCM, GP, PHR, RAD, and MAXR have been added to the Zacks Rank #5 (Strong Sell) List on July 6, 2021
Rite Aid's (RAD) Q1 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Rite Aid's (RAD) Q1 results gain from accelerated vaccinations, the RxEvolution strategy and robust online growth.
New Strong Sell Stocks for June 24th
by Zacks Equity Research
RAD, WTRH, BNR, NMR, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on June 24, 2021
Factors Likely to Influence Rite Aid's (RAD) Q1 Earnings
by Zacks Equity Research
Strength in PBM and Elixir and expanded omnichannel services are likely to have aided Rite Aid (RAD) in Q1. However, rising pandemic costs and low testing demand are likely to have been worrisome.
Rite Aid (RAD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rite Aid's (RAD) Q4 Loss Narrower Than Expected, Sales Beat
by Zacks Equity Research
Rite Aid's (RAD) Q4 results gain from RxEvolution strategy, strength in Elixir brand and robust online growth. However, COVID-related costs woes and lesser cases of cough, cold and flu are concerns.
Factors Likely to Influence Rite Aid's (RAD) Q4 Earnings
by Zacks Equity Research
Solid performance in PBM and Elixir along with expanded omnichannel services is expected to have aided Rite Aid's (RAD) Q4 revenues. However, COVID-19 woes remain concerns.
Michaels (MIK) Steps Up Delivery Game Via Instacart Deal
by Zacks Equity Research
Several retailers are opting for Instacart's same-day delivery service. Michaels (MIK) also follows suit. It launches a pilot program across 100 Michaels stores in Chicago, Dallas and Washington DC.
Rite Aid (RAD) Stock Plunges on Bleak Q4 Business Update
by Zacks Equity Research
Adverse COVID-19 impacts, lesser cases of cold, cough and flu and unfavorable weather weighed on Rite Aid's (RAD) Q4 results. Also, it updated fiscal 2021 view.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence
by Urmimala Biswas
Despite severe COVID-19 challenges, higher demand for telemedicine and federal collaborations for vaccine rollout are likely to lend support to the Zacks Retail - Pharmacies and Drug Stores industry. HLF is well positioned to gain now while CVS and RAD hold huge prospects.
Walgreens (WBA) and UBER Tie Up to Expand COVID Vaccine Access
by Zacks Equity Research
Walgreens (WBA) and UBER to provide up to 10 million free or discounted rides to underserved communities.
Is Rite Aid (RAD) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?
The Zacks Analyst Blog Highlights: Michaels, Rite Aid, DICK'S Sporting Goods, Target and Lowe's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Michaels, Rite Aid, DICK'S Sporting Goods, Target and Lowe's
5 Retail Stocks in Focus as Americans Look Confident Now
by Sumit Singh
Americans feel a bit confident now about the labor market and the overall economic environment. Michaels (MIK), Rite Aid (RAD), DICK'S Sporting (DKS), Target (TGT) and Lowe's (LOW) will be a great addition to your portfolio.
Rite Aid (RAD) Down 9.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moving Average Crossover Alert: Rite Aid (RAD)
by Zacks Equity Research
Rite Aid Corporation (RAD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Here's Why Rite Aid (RAD) Marching Ahead of the Industry
by Zacks Equity Research
Rite Aid (RAD) remains poised for solid growth ahead, driven by strength in online services, PBM market and Elixir.
Are Options Traders Betting on a Big Move in Rite Aid (RAD) Stock?
by Zacks Equity Research
Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.
Has Rite Aid (RAD) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?